MARK2 and cancer: Numerous genes have been confirmed to be downstream targets of these miRNAs, such as the Class IV PI3K mTOR, the tyrosine kinase receptor MET, and the serine/threonine kinase and primary mediator of the PI3K signaling cascade AKT1, all of which are involved in cancer-related phenotypes34,35.